Piper Sandler analyst Mark Fitzgibbon maintains NB Bancorp (NASDAQ:NBBK) with a Overweight and raises the price target from $17 to $20.
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 4/9/2024 | $17.00 | Overweight | Piper Sandler |
NEEDHAM, Mass., Oct. 30, 2024 /PRNewswire/ -- NB Bancorp, Inc. (the "Company") (Nasdaq Capital Market: NBBK), the holding company of Needham Bank (the "Bank"), today announced its third quarter 2024 financial results. SELECTED FINANCIAL HIGHLIGHTS FOR THE THIRD QUARTER OF 2024 Net income of $8.4 million, or $0.21 per diluted share, compared to net income of $9.5 million, or $0.24 per diluted share, for the prior quarter. Operating net income, excluding one-time charges, amounted to $13.1 million, or $0.33 per diluted share for the current quarter. One-time charges include:Loss on the sale of available-for sale securities amounting to $1.9 million;Tax expense and a modified endowment contrac
NEEDHAM, Mass., July 24, 2024 /PRNewswire/ -- NB Bancorp, Inc. (the "Company") (Nasdaq Capital Market: NBBK), the holding company of Needham Bank, today announced its second quarter 2024 financial results. SELECTED FINANCIAL HIGHLIGHTS FOR THE SECOND QUARTER OF 2024 Net income of $9.5 million, or $0.24 per diluted share, compared to net income of $8.7 million, or $0.22 per diluted share, for the prior quarter.Gross loans increased $142.7 million, or 3.6%, to $4.10 billion, from the prior quarter.Net interest margin on a fully-tax equivalent basis decreased 15 basis points to 3.45%.Asset quality remains strong:Annualized net charge-offs of 0.09% of average total loans and non-performing loan
Matthew Cohn of Philadelphia will head the non-profit's volunteer-led Global Mission Board which focuses on special initiatives in type 1 diabetes research, fundraising, community engagement, and advocacy NEW YORK, July 10, 2024 /PRNewswire/ -- Breakthrough T1D, formerly JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, today announced the appointment of Matthew Cohn as the new chair of the non-profit's Global Mission Board. Breakthrough T1D's Global Mission Board is a volunteer-led group, appointed by the organization's board of directors, that focuses on special initiatives in type 1 diabetes research, fundraising, community engagement and advocacy. Matthew
Piper Sandler analyst Mark Fitzgibbon maintains NB Bancorp (NASDAQ:NBBK) with a Overweight and raises the price target from $17 to $20.
NB Bancorp (NASDAQ:NBBK) reported quarterly earnings of $0.24 per share which beat the analyst consensus estimate of $0.23 by 4.35 percent. The company reported $41.70 million in sales this quarter. This is a 19.71 percent increase over sales of $34.84 million the same period last year.
Piper Sandler analyst Mark Fitzgibbon initiates coverage on NB Bancorp (NASDAQ:NBBK) with a Overweight rating and announces Price Target of $17.
SC 13G - NB Bancorp, Inc. (0001979330) (Subject)
SC 13G/A - NB Bancorp, Inc. (0001979330) (Subject)
SC 13G/A - NB Bancorp, Inc. (0001979330) (Subject)
Piper Sandler initiated coverage of NB Bancorp with a rating of Overweight and set a new price target of $17.00
4 - NB Bancorp, Inc. (0001979330) (Issuer)
4 - NB Bancorp, Inc. (0001979330) (Issuer)
4 - NB Bancorp, Inc. (0001979330) (Issuer)
8-K - NB Bancorp, Inc. (0001979330) (Filer)
8-K - NB Bancorp, Inc. (0001979330) (Filer)
8-K - NB Bancorp, Inc. (0001979330) (Filer)
Matthew Cohn of Philadelphia will head the non-profit's volunteer-led Global Mission Board which focuses on special initiatives in type 1 diabetes research, fundraising, community engagement, and advocacy NEW YORK, July 10, 2024 /PRNewswire/ -- Breakthrough T1D, formerly JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, today announced the appointment of Matthew Cohn as the new chair of the non-profit's Global Mission Board. Breakthrough T1D's Global Mission Board is a volunteer-led group, appointed by the organization's board of directors, that focuses on special initiatives in type 1 diabetes research, fundraising, community engagement and advocacy. Matthew
4 - NB Bancorp, Inc. (0001979330) (Issuer)
4 - NB Bancorp, Inc. (0001979330) (Issuer)
4 - NB Bancorp, Inc. (0001979330) (Issuer)
NEEDHAM, Mass., Oct. 30, 2024 /PRNewswire/ -- NB Bancorp, Inc. (the "Company") (Nasdaq Capital Market: NBBK), the holding company of Needham Bank (the "Bank"), today announced its third quarter 2024 financial results. SELECTED FINANCIAL HIGHLIGHTS FOR THE THIRD QUARTER OF 2024 Net income of $8.4 million, or $0.21 per diluted share, compared to net income of $9.5 million, or $0.24 per diluted share, for the prior quarter. Operating net income, excluding one-time charges, amounted to $13.1 million, or $0.33 per diluted share for the current quarter. One-time charges include:Loss on the sale of available-for sale securities amounting to $1.9 million;Tax expense and a modified endowment contrac
NEEDHAM, Mass., July 24, 2024 /PRNewswire/ -- NB Bancorp, Inc. (the "Company") (Nasdaq Capital Market: NBBK), the holding company of Needham Bank, today announced its second quarter 2024 financial results. SELECTED FINANCIAL HIGHLIGHTS FOR THE SECOND QUARTER OF 2024 Net income of $9.5 million, or $0.24 per diluted share, compared to net income of $8.7 million, or $0.22 per diluted share, for the prior quarter.Gross loans increased $142.7 million, or 3.6%, to $4.10 billion, from the prior quarter.Net interest margin on a fully-tax equivalent basis decreased 15 basis points to 3.45%.Asset quality remains strong:Annualized net charge-offs of 0.09% of average total loans and non-performing loan